Liechtenstein
5 Vaccines Approved for Use in Liechtenstein
Protein Subunit
RNA
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
80 trials in 26 countries
Approval Source: ema.europa.eu
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: ema.europa.eu
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
63 trials in 30 countries
Approval Source: ema.europa.eu